Do I need an in-person exam for Ozempic in Texas?

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve probably wondered: Can I actually get these prescriptions through telehealth? The short answer is yes—in most cases, you can legally obtain GLP-1 weight loss medications via telehealth across the United States. But as with many healthcare matters, the details vary by state, and understanding these nuances can help you access safe, effective treatment without unnecessary roadblocks.

Why Telehealth for Weight Loss Medications Makes Sense

The COVID-19 pandemic accelerated the adoption of telemedicine across all areas of healthcare, and weight management is no exception. For many people struggling with obesity, telehealth offers distinct advantages: no need to take time off work for appointments, reduced travel barriers (especially important in rural areas), and the comfort of discussing sensitive health topics from home.

Here’s the crucial regulatory detail most people don’t know: Medications like Wegovy (semaglutide), Ozempic (semaglutide), and Mounjaro (tirzepatide) are not controlled substances under federal law. This means they’re not subject to the Ryan Haight Act’s in-person examination requirement that applies to drugs like Adderall or other stimulants. From a federal standpoint, these weight loss medications can be prescribed via telehealth as long as a legitimate patient-provider relationship is established—typically through a live video consultation.

The Drug Enforcement Administration (DEA) has maintained telehealth flexibilities that were introduced during the pandemic, most recently extending them through December 31, 2025. While these extensions primarily affect controlled medications, they’ve created a broader acceptance of telemedicine prescribing that benefits patients seeking all types of care, including obesity treatment.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Understanding State-Level Variations

While federal law allows telehealth prescribing of GLP-1 medications, individual states add their own layers of regulation. Some states have embraced telehealth wholeheartedly, while others require additional steps to ensure patient safety.

States With Minimal Telehealth Restrictions

California, Washington, New York, and Illinois represent the most telehealth-friendly environments for weight loss medication. In these states:

• No in-person visit is required before or during treatment
• Telehealth consultations are legally equivalent to in-person visits
• Nurse Practitioners (NPs) have full independent practice authority, expanding the pool of available providers
• Electronic prescribing is standard and streamlined

If you live in one of these states, you can typically complete your entire weight loss journey—from initial consultation through ongoing monitoring—via video visits with licensed providers.

States Requiring Initial In-Person Exams

Several states mandate at least one in-person visit as part of obesity treatment, even when using telehealth for ongoing care:

Arkansas has some of the nation’s strictest telemedicine regulations. The state requires providers to conduct an initial in-person physical examination before prescribing weight loss medications via telehealth. This reflects Arkansas’s generally cautious approach to telemedicine—the state currently has one of the most restrictive telehealth frameworks in the country, though legislative efforts to ease these restrictions were under review in late 2025.

Delaware, Georgia, Mississippi, North Dakota, South Carolina, and Texas similarly require an initial in-person evaluation. In Texas, for example, the standard of care typically dictates an in-person exam before starting GLP-1 therapy, even though telehealth follow-ups are permitted. Georgia passed new legislation in 2024 expanding NP and PA prescribing authority for Schedule II drugs, but the state still maintains its initial in-person requirement for weight management medications.

New Jersey and Virginia take this a step further, requiring not just a physical exam but comprehensive baseline testing. New Jersey law mandates an extensive initial evaluation including medical history, physical examination, laboratory work, and psychological screening before any weight-loss medication can be prescribed. Providers must also document that they’ve discussed risks, benefits, and alternatives with patients. Virginia similarly requires an initial physical exam, lab work, and a personalized diet and exercise plan, with mandatory follow-up within 30 days of starting therapy.

States With Special Monitoring Requirements

Florida allows telehealth prescribing but imposes specific conditions: patients must have a BMI of 30 or higher (or 27+ with comorbidities like diabetes or hypertension), and providers must conduct follow-up visits at least once every three months during active treatment. This reflects Florida’s effort to prevent ‘pill mill’ operations while maintaining access to legitimate care.

Connecticut requires providers to include behavioral counseling and a diet/exercise plan as part of any obesity treatment involving medication—telehealth or otherwise. This holistic approach ensures patients receive comprehensive care, not just a prescription.

Who Can Prescribe Weight Loss Medications Via Telehealth?

The type of provider you see for telehealth weight loss care depends significantly on your state’s scope-of-practice laws.

Physicians (MDs and DOs)

All states allow licensed physicians to prescribe GLP-1 medications via telehealth, provided they’re licensed in the state where the patient is physically located during the consultation. This licensing requirement is crucial—your California-licensed doctor cannot treat you via telehealth if you’re vacationing in Florida unless they also hold a Florida medical license (or a special telehealth authorization).

Nurse Practitioners

The landscape for NP prescribing varies dramatically by state. As of late 2025, 34 states plus Washington D.C. grant NPs full independent practice authority—meaning they can evaluate patients, diagnose conditions, and prescribe medications without physician oversight once they meet experience requirements (typically 2-3 years of collaborative practice).

Full Practice Authority States include Arizona, California, Colorado, Connecticut, Hawaii, Idaho, Iowa, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, Washington, Wisconsin, Wyoming, Alaska, Delaware, and the District of Columbia.

In these states, you might see an NP for your entire telehealth weight loss journey, and they have the same prescribing authority as physicians for non-controlled medications like GLP-1s.

Collaborative Practice States like Florida, Georgia, Illinois, Pennsylvania, and Texas require NPs to work under some form of physician collaboration or supervision agreement. This doesn’t mean a physician must be present for your telehealth visit, but the NP must have a formal relationship with a supervising physician. In practice, many telehealth platforms in these states employ both physicians and NPs to ensure seamless care.

Notably, Georgia recently expanded NP authority through legislation effective July 2024, now allowing NPs and PAs to prescribe Schedule II controlled substances with physician delegation—a significant step forward, though it doesn’t affect non-controlled GLP-1 medications which NPs could already prescribe.

Physician Assistants

PAs can prescribe weight loss medications in all states, but like NPs, they work under varying degrees of physician supervision depending on state law. The collaboration requirements mirror those for NPs in most jurisdictions.

What Patients Need to Qualify for Telehealth Weight Loss Prescriptions

Reputable telehealth providers follow the same clinical guidelines as in-person obesity medicine practices. Here’s what to expect:

Clinical Eligibility Criteria

BMI Requirements: Generally, you’ll need a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as:

• Type 2 diabetes or prediabetes
• High blood pressure
• High cholesterol
• Obstructive sleep apnea
• Cardiovascular disease

Medical History Screening: Providers will ask detailed questions about:

• Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (absolute contraindications)
• History of pancreatitis or gallbladder disease
• Current medications and allergies
• Previous weight loss attempts
• Mental health conditions (especially eating disorders)
• Pregnancy status and plans (GLP-1s must be discontinued before pregnancy)

The Typical Telehealth Evaluation Process

A legitimate telehealth weight loss consultation isn’t a quick questionnaire—it’s a comprehensive medical evaluation delivered via video. Here’s what happens:

1. Detailed Intake Questionnaire: You’ll complete an extensive health history covering medical conditions, medications, weight history, lifestyle factors, and treatment goals.

2. Live Video Consultation: A licensed provider (MD, DO, or NP depending on your state) will review your information, discuss your health goals, explain how GLP-1 medications work, review potential side effects, and determine if you’re an appropriate candidate. This typically takes 20-30 minutes.

3. Physical Assessment (When Required): In states requiring in-person exams, you may need to visit a local clinic or lab for baseline measurements, vital signs, and blood work. Some telehealth platforms partner with national lab networks to facilitate this.

4. Treatment Plan Development: If approved, your provider will create a personalized plan including medication dosing schedule, dietary recommendations, exercise goals, and a follow-up timeline.

5. Prescription and Pharmacy Coordination: The provider electronically sends your prescription to a pharmacy of your choice (many states mandate e-prescribing). You’ll typically start with a 4-week supply to assess tolerance.

Medication Options and Considerations

Wegovy (Semaglutide 2.4mg)

FDA Status: Approved specifically for chronic weight management in adults with obesity or overweight with comorbidities.

Telehealth Prescribing: Fully permitted in all states via telehealth (subject to state-specific in-person requirements where applicable).

Key Points:

• Once-weekly self-injection
• Gradual dose escalation over 16-20 weeks to the target 2.4mg dose
• Average weight loss of 15-17% of body weight in clinical trials
• Common side effects include nausea, diarrhea, constipation, and fatigue (usually improve over time)

Important 2025 Update: The FDA banned routine compounding of semaglutide for weight loss effective May 2025. This means you should only receive FDA-approved, brand-name Wegovy through legitimate pharmacies—beware of telehealth services offering ‘compounded semaglutide’ at lower prices, as these may not meet quality standards.

Ozempic (Semaglutide 0.5-1mg)

FDA Status: Approved for type 2 diabetes; commonly prescribed off-label for weight loss.

Telehealth Prescribing: Legal via telehealth, but providers must document the off-label use rationale and obtain informed consent from patients.

Key Points:

• Same active ingredient as Wegovy but at different dosing
• Originally developed for blood sugar control
• Often used for weight loss when Wegovy is unavailable or insurance doesn’t cover it
• Patients without diabetes should understand this is off-label use

Mounjaro (Tirzepatide) / Zepbound

FDA Status: Mounjaro approved for type 2 diabetes; Zepbound (same drug, higher doses) approved for weight loss in late 2023.

Telehealth Prescribing: Permitted in all states via telehealth following appropriate evaluation.

Key Points:

• Dual-action medication (GLP-1 and GIP receptor agonist)
• Once-weekly injection
• Clinical trials showed average weight loss of 20-22% of body weight
• Newer option with potentially greater efficacy for some patients
• Similar side effect profile to semaglutide

Safety Considerations and Red Flags

The popularity of weight loss medications has unfortunately attracted some less-than-reputable telehealth operations. Here’s how to protect yourself:

Warning Signs of Problematic Telehealth Services

🚩 Guaranteed Prescriptions: Legitimate providers evaluate each patient individually. Any service promising ‘guaranteed approval’ or ‘everyone qualifies’ is cutting corners on medical evaluation.

🚩 No Live Provider Interaction: While questionnaires are part of the process, you should always have a live video consultation with a licensed clinician. Asynchronous-only services (questionnaire-based prescribing with no video visit) don’t meet the standard for establishing a valid patient-provider relationship in most states.

🚩 Compounded or International Medications: After the FDA’s 2025 ban on compounded semaglutide, any service offering significantly cheaper ‘compounded Wegovy’ is violating federal regulations. Similarly, avoid services shipping medications from overseas pharmacies—these may contain counterfeit or contaminated products.

🚩 No Follow-up or Monitoring: Responsible weight loss treatment requires ongoing monitoring for side effects, dose adjustments, and progress tracking. Be suspicious of services that don’t schedule regular check-ins.

🚩 Unclear Provider Credentials: You should be able to easily verify your provider’s name, credentials, and state license number. Avoid services that won’t disclose who will be prescribing or where they’re licensed.

What Legitimate Telehealth Should Include

✅ Thorough Medical Screening: Comprehensive questionnaire plus live consultation

✅ Licensed Providers: Clear disclosure of provider credentials and state licensure

✅ Informed Consent Process: Discussion of risks, benefits, alternatives, and side effects

✅ Lifestyle Counseling: Guidance on diet, exercise, and behavioral changes alongside medication

✅ Regular Follow-ups: Scheduled check-ins (typically monthly initially, then every 2-3 months once stable)

✅ Lab Monitoring (When Appropriate): For patients with diabetes or other conditions, periodic lab work to monitor metabolic parameters

✅ Clear Pricing: Transparent consultation fees and medication costs (telehealth platforms should disclose whether they accept insurance or operate on a cash-pay model)

How Klarity Health Approaches Telehealth Weight Loss Care

At Klarity Health, we’ve designed our weight loss program to combine the convenience of telehealth with the clinical rigor of in-person obesity medicine. Here’s what sets us apart:

Provider Availability: We maintain a network of licensed MDs, DOs, and NPs across multiple states, ensuring you can connect with a qualified provider regardless of your location. Our providers are credentialed in your specific state and stay current on local telehealth regulations.

Transparent Pricing: We accept both insurance and offer clear cash-pay pricing for those without coverage or who prefer to pay out-of-pocket. You’ll know the consultation cost upfront—no surprise bills.

Comprehensive Evaluation: Every patient receives a thorough medical assessment including review of contraindications, current medications, and personalized treatment planning. We don’t just prescribe medication; we partner with you on sustainable weight management.

State Compliance: Our platform automatically routes you to appropriately licensed providers and ensures compliance with your state’s specific requirements—whether that’s arranging an initial in-person exam in Texas or coordinating baseline lab work in New Jersey.

Ongoing Support: Weight loss isn’t a one-time prescription. We provide regular follow-up visits, dose adjustments as needed, and counseling on lifestyle modifications that enhance medication effectiveness.

The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve in favor of expanded telehealth access. Several trends are worth noting:

Federal Level: The DEA’s current telehealth flexibilities are temporary, set to expire December 31, 2025, but strong signals suggest another extension or permanent framework is coming. Congress is considering legislation like the TREATS Act, which would make some telehealth prescribing flexibilities permanent—reflecting bipartisan recognition that telehealth improves access to care, especially for underserved populations.

State Level: The trend is toward fewer restrictions, not more. States that previously required in-person visits for all telemedicine are gradually updating their laws. Several states including Mississippi and Pennsylvania have pending legislation to grant NPs full practice authority, which would further expand the provider pool for telehealth weight loss services.

Technology Integration: Expect to see more integration between telehealth platforms and remote monitoring devices (smart scales, continuous glucose monitors, wearable activity trackers) that allow providers to track patient progress in real-time and adjust treatment plans accordingly.

Insurance Coverage: As telehealth becomes standard rather than exceptional, more insurance plans are covering both telehealth consultations and the weight loss medications themselves. Medicare now covers certain obesity counseling via telehealth, and private insurers are expanding coverage of GLP-1 medications for weight management (though coverage remains inconsistent).

Frequently Asked Questions

Do I need to live in the same state as my telehealth provider?

No, but your provider must be licensed in the state where you are physically located during the consultation. Many telehealth platforms (including Klarity Health) employ providers licensed in multiple states to serve patients nationwide. You cannot receive care from a California-licensed provider if you’re in Texas unless that provider also holds a Texas medical license.

How quickly can I get started?

In states without in-person requirements, you can often complete your initial consultation within a few days of signing up. If your state requires baseline lab work or an in-person exam, the timeline extends by 1-2 weeks while you complete those requirements. Once approved, prescriptions are typically sent to your pharmacy within 24 hours.

Will my insurance cover telehealth weight loss treatment?

Coverage varies significantly. Some insurance plans cover both the consultation and the medication; others cover one but not the other; some cover neither. It’s worth checking with your insurance—even if they don’t cover the medication, they may cover the telehealth visit as a standard medical consultation. Klarity Health’s team can help verify your benefits before your appointment.

What if I have side effects?

GLP-1 medications commonly cause gastrointestinal side effects, especially when starting or increasing doses. Most are manageable and improve within a few weeks. Your telehealth provider should be available for questions between scheduled visits. At Klarity Health, patients can message their provider through our secure platform and schedule urgent consultations if needed.

Can I switch from in-person care to telehealth (or vice versa)?

Yes. If you’re currently seeing a provider in person, you can often transition to telehealth follow-ups once you’re stable on medication. Conversely, if you start with telehealth and later want in-person care, your telehealth provider can coordinate the transfer and share medical records with your new provider.

Are there age restrictions?

Most telehealth weight loss programs serve adults 18 and older. Wegovy was recently approved for adolescents aged 12+ with obesity, but telehealth prescribing for minors involves additional legal considerations (parental consent, state-specific minor consent laws) that vary by jurisdiction. Some platforms offer adolescent weight management; others focus exclusively on adults.

What happens if I move to a different state during treatment?

You’ll need to transition to a provider licensed in your new state. Established telehealth platforms like Klarity Health can often facilitate this seamlessly by connecting you with one of our providers in your new state and transferring your medical records internally.

Taking the Next Step

If you’re struggling with obesity and traditional weight loss methods haven’t worked, telehealth provides an accessible path to evidence-based medical treatment. The key is choosing a reputable provider that prioritizes your safety and long-term success over quick prescriptions.

Before your consultation, gather:

• Current height and weight measurements
• List of all medications and supplements
• Records of recent lab work (if available)
• Summary of previous weight loss attempts
• Any relevant medical history (diabetes, thyroid conditions, cardiovascular disease, etc.)

Questions to ask during your consultation:

• What are realistic weight loss expectations with this medication?
• How will we monitor for side effects?
• What lifestyle changes should I make alongside medication?
• How long will I need to take this medication?
• What happens if I stop taking it?
• What are the costs (consultation, medication, follow-ups)?

Remember: effective weight management combines medication with sustainable lifestyle changes. The most successful patients use GLP-1 medications as tools to support healthier eating patterns and increased physical activity—not as standalone solutions.

Ready to Explore Your Options?

Klarity Health makes it simple to get started with telehealth weight loss treatment, regardless of your state’s specific requirements. Our platform handles the complexity of multi-state licensing and regulatory compliance, so you can focus on your health goals.

Visit Klarity Health today to:

• Complete a free eligibility assessment
• Schedule a consultation with a licensed provider in your state
• Get transparent pricing for both cash-pay and insurance options
• Access ongoing support throughout your weight loss journey

Whether you’re in a telehealth-friendly state like California or navigating more complex requirements in Texas or New Jersey, Klarity Health’s team will guide you through every step—from your first consultation through achieving your weight loss goals.

Your healthier future is just a video call away.

Sources and References

1. DEA Announcement (Nov 2024) – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ – Official government release (DEA.gov), Nov 15, 2024

2. Axios News – ‘COVID-era telehealth prescribing extended’ – News media coverage, Nov 18, 2024

3. McDermott Will & Emery Law Firm – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025’ – Legal analysis, Nov 18, 2024

4. Goodwin Procter Law Firm – ‘The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs’ – Healthcare law alert, Mar 27, 2024

5. Reuters – ‘Hims cuts 4% of workforce amid ban on weight-loss drug copies’ – News report on FDA compounding ban, May 30, 2025

Research verified as of December 17, 2025. Federal DEA telehealth flexibilities remain in effect through December 31, 2025. State regulations are subject to change; this guide reflects current law as of publication date. For the most current information specific to your situation, consult with a licensed healthcare provider in your state.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid